T1D Fund: A Breakthrough T1D Venture
Deals on record
1
Common Fundraising Type
Series B
Aspect Biosystems
Bioprinted tissue
Aspect Biosystems develops bioprinted tissue therapeutics to treat serious metabolic and endocrine diseases using AI-powered bioprinting technology.